SKYE

Skye Bioscience, Inc.$2.05+0.06 (+3.02%)

Prev Close$1.99·MCap$8.9M·P/E—·Vol27.2K·Yield—

▲

Buys (12M)

$0.00

▼

Sells (12M)

$280.6K

◆

Net Activity

Net Seller

$280.6K

●

Active Insiders

last 12 mo

Over the past 12 months, insider activity at Skye Bioscience, Inc. (SKYE) has been exclusively selling, with 0 insider purchases totaling $0.00 and 2 insider sales totaling $280.6K. The most recent insider transaction was by Schwab Andrew J. (director, 10 percent owner: ), who sold $140.3K worth of shares on Aug 20, 2026. Skye Bioscience, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $8.9M.

SKYE Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Aug 20, 2026	Schwab Andrew J.	director, 10 percent owner:	Sell	375,840	$0.37	$140.3K1.1% OS	7,914,126
Aug 20, 2026	5AM Partners VII, LLC	10 percent owner	Sell	375,840	$0.37	$140.3K1.1% OS	7,914,126
Aug 21, 2025	Schwab Andrew J.	Director	Sell	231,405	$3.46	$800.5K0.7% OS	0
Nov 20, 2024	Diep Tuan Tu	Chief Development Officer	Sell	19,574	$4.99	$97.7K	101,748
Nov 19, 2024	ARSENAULT KAITLYN	Chief Financial Officer	Sell	43,396	$4.99	$216.7K	209,548
Nov 19, 2024	DHILLON PUNIT	Chief Executive Officer	Sell	82,910	$4.99	$413.9K	412,369
Nov 19, 2024	Grayson Paul A.	Director	Sell	86,551	$4.99	$432.1K	345,945
Sep 13, 2024	Schwab Andrew J.		Sell	266,337	$6.57	$1.75M0.8% OS	8,178,964
Mar 15, 2024	5AM Partners VII, LLC		Buy	450,000	$10.00	$4.50M1.3% OS	8,393,520
Feb 2, 2024	5AM Partners VII, LLC	10% Owner	Buy	5,206,074	$2.31	$12.03M15.6% OS	7,943,520+190%
Aug 29, 2023	DHILLON PUNIT	Chief Executive Officer	Buy	881,000	$0.02	$16.5K2.6% OS	41,554,828

SKYE Insider Buying Activity

The following table shows recent insider purchases of Skye Bioscience, Inc. (SKYE) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Mar 15, 2024	5AM Partners VII, LLC		Buy	450,000	$10.00	$4.50M1.3% OS	8,393,520
Feb 2, 2024	5AM Partners VII, LLC	10% Owner	Buy	5,206,074	$2.31	$12.03M15.6% OS	7,943,520+190%
Aug 29, 2023	DHILLON PUNIT	Chief Executive Officer	Buy	881,000	$0.02	$16.5K2.6% OS	41,554,828

SKYE Insider Selling Activity

The following table shows recent insider sales of Skye Bioscience, Inc. (SKYE) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Aug 20, 2026	Schwab Andrew J.	director, 10 percent owner:	Sell	375,840	$0.37	$140.3K1.1% OS	7,914,126
Aug 20, 2026	5AM Partners VII, LLC	10 percent owner	Sell	375,840	$0.37	$140.3K1.1% OS	7,914,126
Aug 21, 2025	Schwab Andrew J.	Director	Sell	231,405	$3.46	$800.5K0.7% OS	0
Nov 20, 2024	Diep Tuan Tu	Chief Development Officer	Sell	19,574	$4.99	$97.7K	101,748
Nov 19, 2024	ARSENAULT KAITLYN	Chief Financial Officer	Sell	43,396	$4.99	$216.7K	209,548
Nov 19, 2024	DHILLON PUNIT	Chief Executive Officer	Sell	82,910	$4.99	$413.9K	412,369
Nov 19, 2024	Grayson Paul A.	Director	Sell	86,551	$4.99	$432.1K	345,945
Sep 13, 2024	Schwab Andrew J.		Sell	266,337	$6.57	$1.75M0.8% OS	8,178,964